Article
Fibroblast growth factor-2 (FGF2) augmentation early in life alters hippocampal development and rescues the anxiety phenotype in vulnerable animals.
Proceedings of the National Academy of Sciences of the United States of America - 10 May 2011
Turner Cortney A, Clinton Sarah M, Thompson Robert C, Watson Stanley J, Akil Huda
Abstract excerpt
Individuals with mood disorders exhibit alterations in the fibroblast growth factor system, including reduced hippocampal fibroblast growth factor-2 (FGF2). It is difficult, however, to pinpoint whether these alterations are a cause or consequence of the disorder. The present study asks whether FGF2 administered the day after birth has long-lasting effects on hippocampal development and emotionality. We show that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
